Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRAPARIB vs NITRENDIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRAPARIB vs NITRENDIPINE: Safety Overview

Metric NIRAPARIB NITRENDIPINE
Total FAERS Reports 21,634 353
Deaths Reported 1,370 13
Death Rate 6.3% 3.7%
Hospitalizations 4,892 243
Average Patient Age 65.7 yrs 70.9 yrs
% Female Patients 98.5% 41.9%
FDA Approval Date Apr 26, 2023 N/A
Manufacturer GlaxoSmithKline LLC N/A
Route ORAL N/A
Marketing Status Discontinued N/A